# An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

> **NCT07184996** · PHASE3 · RECRUITING · sponsor: **Sanofi** · enrollment: 980 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Duvakitug
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07184996
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-08
- **Primary completion:** 2028-05-09
- **Final completion:** 2028-05-09
- **Target enrollment:** 980 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07184996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07184996, "An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07184996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*